<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="osanctum-searched/PMC5486092/results/search/drugs/results.xml">
  <result pre="more accessible to an antibiotic treatment. Accordingly, the effectiveness of" exact="tobramycin" post="combined with purified compounds was evaluated on one-day-old biofilms."/>
  <result pre="β-sitosterol or α-amyrin (100 µM) considerably improved the effectiveness of" exact="tobramycin" post="(50 μg/mL = 107 µM) against P. aeruginosa PA01"/>
  <result pre="FICI tobramycin/α-amyrin = 1), suggesting that the increased effectiveness of" exact="tobramycin" post="in biofilm-encapsulated bacteria is not associated with an increase"/>
  <result pre="to disperse preformed biofilm and to improve the effectiveness of" exact="tobramycin" post="towards biofilm-encapsulated P. aeruginosa PAO1 are encouraging for further"/>
  <result pre="rpm) in LB-MOPS broth (50 mM, pH 7) supplemented with" exact="carbenicillin" post="(300 µg/mL) or tetracycline (15 µg/mL) when appropriate. Plasmids"/>
  <result pre="(50 mM, pH 7) supplemented with carbenicillin (300 µg/mL) or" exact="tetracycline" post="(15 µg/mL) when appropriate. Plasmids ( Table S1) were"/>
  <result pre="susceptibility of biofilm-encapsulated P. aeruginosa PAO1 cells was assessed using" exact="tobramycin" post="as previously described [ 4]. Briefly, P. aeruginosa PAO1"/>
  <result pre="grown statically for 24 h to form biofilms, incubated with" exact="tobramycin" post="(50 μg/mL = 107 µM) and DMSO (1%) or"/>
  <result pre="64. Imperi F. Leoni L. Visca P. Anti-virulence activity of" exact="azithromycin" post="in Pseudomonas aeruginosa Front. Microbiol. 2014 5 178 10.3389/fmicb.2014.00178"/>
 </snippets>
</snippetsTree>
